Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Depression symptoms and treatment among HIV infected and uninfected veterans.
Sueoka K, Goulet JL, Fiellin DA, Rimland D, Butt AA, Gibert C, Rodriguez-Barradas MC, Bryant K, Crystal S, Justice AC. Sueoka K, et al. Among authors: fiellin da. AIDS Behav. 2010 Apr;14(2):272-9. doi: 10.1007/s10461-008-9428-7. Epub 2008 Jul 22. AIDS Behav. 2010. PMID: 18648927 Free PMC article.
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R; BHIVES Collaborative. Altice FL, et al. Among authors: fiellin da. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S22-32. doi: 10.1097/QAI.0b013e318209751e. J Acquir Immune Defic Syndr. 2011. PMID: 21317590 Free PMC article. Clinical Trial.
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.
Fiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman LB, Chaudhry A, Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, O'Connor PG; BHIVES Collaborative. Fiellin DA, et al. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(0 1):S33-8. doi: 10.1097/QAI.0b013e3182097537. J Acquir Immune Defic Syndr. 2011. PMID: 21317592 Free PMC article. Clinical Trial.
Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.
Korthuis PT, Tozzi MJ, Nandi V, Fiellin DA, Weiss L, Egan JE, Botsko M, Acosta A, Gourevitch MN, Hersh D, Hsu J, Boverman J, Altice FL; BHIVES Collaborative. Korthuis PT, et al. Among authors: fiellin da. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S39-45. doi: 10.1097/QAI.0b013e318209754c. J Acquir Immune Defic Syndr. 2011. PMID: 21317593 Free PMC article.
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.
Schackman BR, Leff JA, Botsko M, Fiellin DA, Altice FL, Korthuis PT, Sohler N, Weiss L, Egan JE, Netherland J, Gass J, Finkelstein R; BHIVES Collaborative. Schackman BR, et al. Among authors: fiellin da. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S76-82. doi: 10.1097/QAI.0b013e31820a9a66. J Acquir Immune Defic Syndr. 2011. PMID: 21317599 Free PMC article.
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D; BHIVES Collaborative. Korthuis PT, et al. Among authors: fiellin da. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S83-90. doi: 10.1097/QAI.0b013e31820bc9a5. J Acquir Immune Defic Syndr. 2011. PMID: 21317600 Free PMC article.
401 results